UCBUCBUCB

UCB

No trades
See on Supercharts
Market capitalization
‪22.68 B‬EUR
‪343.00 M‬EUR
‪5.25 B‬EUR
‪117.23 M‬
Beta (1Y)
1.02

About UCB

CEO
Jean-Christophe Tellier
Headquarters
Brussels
Website
Employees (FY)
‪9.08 K‬
Founded
1925
ISIN
BE0003739530
FIGI
BBG000BD8CR4
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of UCB is 121.20 EUR — it has increased by 1.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange UCB stocks are traded under the ticker UCB.
UCB is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
UCB stock is 2.53% volatile and has beta coefficient of 1.02. Check out the list of the most volatile stocks — is UCB there?
One year price forecast for UCB has a max estimate of 165.00 EUR and a min estimate of 105.00 EUR.
UCB earnings for the last quarter are 2.63 EUR per share, whereas the estimation was 1.69 EUR resulting in a 55.93% surprise. The estimated earnings for the next quarter are 1.34 EUR per share. See more details about UCB earnings.
UCB revenue for the last quarter amounts to ‪2.59 B‬ EUR despite the estimated figure of ‪2.54 B‬ EUR. In the next quarter revenue is expected to reach ‪2.54 B‬ EUR.
Yes, you can track UCB financials in yearly and quarterly reports right on TradingView.
UCB stock has risen by 3.02% compared to the previous week, the month change is a 12.22% rise, over the last year UCB has showed a 41.00% increase.
UCB net income for the last quarter is ‪32.00 M‬ EUR, while the quarter before that showed ‪311.00 M‬ EUR of net income which accounts for −89.71% change. Track more UCB financial stats to get the full picture.
Today UCB has the market capitalization of ‪22.77 B‬, it has decreased by 0.30% over the last week.
Yes, UCB dividends are paid annually. The last dividend per share was 0.93 EUR. As of today, Dividend Yield (TTM)% is 0.78%. Tracking UCB dividends might help you take more informed decisions.
UCB dividend yield was 1.21% in 2023, and payout ratio reached 52.65%. The year before the numbers were 1.27% and 42.23% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, UCB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UCB stock right from TradingView charts — choose your broker and connect to your account.
UCB reached its all-time high on Apr 12, 2024 with the price of 122.60 EUR, and its all-time low was 16.80 EUR and was reached on Oct 24, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪9.08 K‬ employees. See our rating of the largest employees — is UCB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UCB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UCB stock shows the strong buy signal. See more of UCB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on UCB future price: according to them, UCB price has a max estimate of 165.00 EUR and a min estimate of 105.00 EUR. Read a more detailed UCB forecast: see what analysts think of UCB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UCB EBITDA is ‪1.35 B‬ EUR, and current EBITDA margin is 18.47%. See more stats in UCB financial statements.